Back
AstraZeneca PLC Vs. Fusion Pharmaceuticals Industry Stock Comparison
Buy
67
AZN
AstraZeneca PLC
Last Price:
77.04
Seasonality Move:
2.56%
Buy
80
FUSN
Fusion Pharmaceuticals
Last Price:
21.44
Seasonality Move:
-30.39%
Buy
67
AstraZeneca PLC (AZN)
is a Buy
Is AstraZeneca PLC a Buy, Sell or Hold?
- The current AstraZeneca PLC [AZN] share price is $77.43. The Score for AZN is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- AZN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Fusion Pharmaceuticals (FUSN)
is a Buy
Is Fusion Pharmaceuticals a Buy, Sell or Hold?
- The current Fusion Pharmaceuticals [FUSN] share price is $21.43. The Score for FUSN is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- FUSN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AZN Stock Price Chart
What is AstraZeneca PLC's stock price today?
-
The AstraZeneca PLC share price today is $77.43
The current trend is moderately bullish and AZN is experiencing buying pressure, which is a positive indicator for future bullish movement.
FUSN Stock Price Chart
What is Fusion Pharmaceuticals's stock price today?
-
The Fusion Pharmaceuticals share price today is $21.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FUSN is experiencing slight selling pressure.
AZN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.4 | Buy |
| Relative Strength Index (14 RSI): | 76.41 | Buy |
| Chaikin Money Flow: | 1438985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.16 - 76.52) | Buy |
| Bollinger Bands (100): | (64.27 - 71.65) | Buy |
FUSN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 74.17 | Buy |
| Chaikin Money Flow: | -44455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.3 - 21.44) | Buy |
| Bollinger Bands (100): | (8.95 - 20.13) | Buy |
AZN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.68 | Buy |
| 20-day SMA: | 73.87 | Buy |
| 50-day SMA: | 69.72 | Buy |
| 200-day SMA: | 67.26 | Buy |
| 8-day EMA: | 76.6 | Buy |
| 20-day EMA: | 74.38 | Buy |
| 50-day EMA: | 71.04 | Buy |
| 200-day EMA: | 68.02 | Buy |
FUSN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.43 | Sell |
| 20-day SMA: | 21.38 | Buy |
| 50-day SMA: | 18.84 | Buy |
| 200-day SMA: | 9.13 | Buy |
| 8-day EMA: | 21.42 | Buy |
| 20-day EMA: | 21.18 | Buy |
| 50-day EMA: | 19.01 | Buy |
| 200-day EMA: | 11.56 | Buy |
AstraZeneca PLC Earnings Growth & AZN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.21 per share, an increase this year of $0.40 per share, and an increase next year of $0.70 per share.
Fusion Pharmaceuticals Earnings Growth & FUSN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.18 per share.
AstraZeneca PLC Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fusion Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||